These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1469094)

  • 41. Antithrombin.
    Hepner M; Karlaftis V
    Methods Mol Biol; 2013; 992():355-64. PubMed ID: 23546728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular basis of inherited antithrombin deficiency in Portuguese families: identification of genetic alterations and screening for additional thrombotic risk factors.
    David D; Ribeiro S; Ferrão L; Gago T; Crespo F
    Am J Hematol; 2004 Jun; 76(2):163-71. PubMed ID: 15164384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antithrombin Chicago, amino acid substitution of arginine 393 to histidine.
    Erdjument H; Lane DA; Panico M; Di Marzo V; Morris HR; Bauer K; Rosenberg RD
    Thromb Res; 1989 Jun; 54(6):613-9. PubMed ID: 2781509
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microheterogeneity of antithrombin III: effect of single amino acid substitutions and relationship with functional abnormalities.
    De Stefano V; Leone G; Mastrangelo S; Lane DA; Girolami A; de Moerloose P; Sas G; Abildgaard U; Blajchman M; Rodeghiero F
    Blood Coagul Fibrinolysis; 1994 Feb; 5(1):7-15. PubMed ID: 8180341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antithrombin III Utah: proline-407 to leucine mutation in a highly conserved region near the inhibitor reactive site.
    Bock SC; Marrinan JA; Radziejewska E
    Biochemistry; 1988 Aug; 27(16):6171-8. PubMed ID: 3191114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity.
    Dementiev A; Petitou M; Herbert JM; Gettins PG
    Nat Struct Mol Biol; 2004 Sep; 11(9):863-7. PubMed ID: 15311268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antithrombin "Chicago": a functionally abnormal molecule with increased heparin affinity causing familial thrombophilia.
    Bauer KA; Ashenhurst JB; Chediak J; Rosenberg RD
    Blood; 1983 Dec; 62(6):1242-50. PubMed ID: 6640109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two novel antithrombin variants, Asn187Asp and Asn187Lys, indicate a functional role for asparagine 187.
    Perry DJ; Marshall C; Borg JY; Tait RC; Daly ME; Walker ID; Carrell RW
    Blood Coagul Fibrinolysis; 1995 Feb; 6(1):51-4. PubMed ID: 7795154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two new antithrombin variants support a role for K114 and R13 in heparin binding.
    Picard V; Susen S; Bellucci S; Aiach M; Alhenc-Gelas M
    J Thromb Haemost; 2003 Feb; 1(2):386-7. PubMed ID: 12871518
    [No Abstract]   [Full Text] [Related]  

  • 50. Mutation of the H-helix in antithrombin decreases heparin stimulation of protease inhibition.
    Gonzales PR; Walston TD; Camacho LO; Kielar DM; Church FC; Rezaie AR; Cooper ST
    Biochim Biophys Acta; 2007 Nov; 1774(11):1431-7. PubMed ID: 17905675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
    Rosenberg RD
    Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of a novel, rapid assay for detection of heparin-binding defect antithrombin deficiencies: the heparin-antithrombin binding (HAB) ratio.
    Moore GW; de Jager N; Cutler JA
    Thromb Res; 2015 Jan; 135(1):161-6. PubMed ID: 25466846
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antithrombin Budapest 3. An antithrombin variant with reduced heparin affinity resulting from the substitution L99F.
    Olds RJ; Lane DA; Boisclair M; Sas G; Bock SC; Thein SL
    FEBS Lett; 1992 Apr; 300(3):241-6. PubMed ID: 1555650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency.
    van Boven HH; Reitsma PH; Rosendaal FR; Bayston TA; Chowdhury V; Bauer KA; Scharrer I; Conard J; Lane DA
    Thromb Haemost; 1996 Mar; 75(3):417-21. PubMed ID: 8701400
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").
    Sambrano JE; Jacobson LJ; Reeve EB; Manco-Johnson MJ; Hathaway WE
    J Clin Invest; 1986 Mar; 77(3):887-93. PubMed ID: 3512602
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Importance of the release of strand 1C to the polymerization mechanism of inhibitory serpins.
    Chang WS; Whisstock J; Hopkins PC; Lesk AM; Carrell RW; Wardell MR
    Protein Sci; 1997 Jan; 6(1):89-98. PubMed ID: 9007980
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Further investigations on antithrombin III in the plasmas of patients with the abnormality of antithrombin III Budapest.
    Sas G; Pepper DS; Cash JD
    Thromb Diath Haemorrh; 1975 Jun; 33(3):564-72. PubMed ID: 1154312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Site-directed mutagenesis of the P2 residue of human antithrombin.
    Sheffield WP; Blajchman MA
    FEBS Lett; 1994 Feb; 339(1-2):147-50. PubMed ID: 8313964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carbohydrate isoforms of antithrombin variant N135Q with different heparin affinities.
    Turko IV; Fan B; Gettins PG
    FEBS Lett; 1993 Nov; 335(1):9-12. PubMed ID: 8243674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.